Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression
-
- Katsuyuki Tanabe
- Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan
-
- Yasufumi Sato
- Department of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai 980-8575, Japan
-
- Jun Wada
- Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan
書誌事項
- 公開日
- 2018-06-24
- 資源種別
- journal article
- 権利情報
-
- https://creativecommons.org/licenses/by/4.0/
- DOI
-
- 10.3390/ijms19071859
- 公開者
- MDPI AG
説明
<jats:p>Chronic kidney disease (CKD) is a major global health problem. Unless intensive intervention is initiated, some patients can rapidly progress to end-stage kidney disease. However, it is often difficult to predict renal outcomes using conventional laboratory tests in individuals with CKD. Therefore, many researchers have been searching for novel biomarkers to predict the progression of CKD. Angiogenesis is involved in physiological and pathological processes in the kidney and is regulated by the balance between a proangiogenic factor, vascular endothelial growth factor (VEGF)-A, and various endogenous antiangiogenic factors. In recent reports using genetically engineered mice, the roles of these antiangiogenic factors in the pathogenesis of kidney disease have become increasingly clear. In addition, recent clinical studies have demonstrated associations between circulating levels of antiangiogenic factors and renal dysfunction in CKD patients. In this review, we summarize recent advances in the study of representative endogenous antiangiogenic factors, including soluble fms-related tyrosine kinase 1, soluble endoglin, pigment epithelium-derived factor, VEGF-A165b, endostatin, and vasohibin-1, in associations with kidney diseases and discuss their predictive potentials as biomarkers of progression of CKD.</jats:p>
収録刊行物
-
- International Journal of Molecular Sciences
-
International Journal of Molecular Sciences 19 (7), 1859-, 2018-06-24
MDPI AG
- Tweet
キーワード
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factor Receptor-1
- Angiogenesis Inhibitors
- Cell Cycle Proteins
- Review
- Endostatins
- Mice
- Gene Expression Regulation
- Disease Progression
- Animals
- Humans
- Kidney Failure, Chronic
- Angiogenesis Inducing Agents
- Nerve Growth Factors
- Renal Insufficiency, Chronic
- Eye Proteins
- Biomarkers
- Serpins
詳細情報 詳細情報について
-
- CRID
- 1360004239494864000
-
- ISSN
- 14220067
-
- PubMed
- 29937525
-
- 資料種別
- journal article
-
- データソース種別
-
- Crossref
- KAKEN
- OpenAIRE
